NVO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Novo Nordisk A/S's quarterly accounts payable declined from Dec. 2013 ($1,152 Mil) to Mar. 2014 ($1,110 Mil) and declined from Mar. 2014 ($1,110 Mil) to Jun. 2014 ($817 Mil).
Novo Nordisk A/S's annual accounts payable increased from Dec. 2011 ($775 Mil) to Dec. 2012 ($794 Mil) and increased from Dec. 2012 ($794 Mil) to Dec. 2013 ($1,152 Mil).
Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.
It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Novo Nordisk A/S Annual Data
Novo Nordisk A/S Quarterly Data